STAT
AUGUST 15, 2023
The company — which is a major supplier of non-human primates to corporate, government, and academic research laboratories — received a voluntary request last May for documents dating back to December 2017 about importing non-human primates from Asia, according to a regulatory filing. ( See page 42.)
STAT
AUGUST 16, 2023
The company — which is a major supplier of non-human primates to corporate, government, and academic research laboratories — received a voluntary request last May for documents dating back to December 2017 about importing non-human primates from Asia, according to a regulatory filing.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog: Biosimilars
DECEMBER 11, 2023
OHT-7’s well documented meltdown during the COVID-19 public health emergency should serve as an object lesson. Even if MDUFA VI were to allow the hiring of a significant number of new personnel, implementation of the Proposed Rule would begin before those employees arrive. 4] PRIA at 28. [5] 68006, 68012 (Oct.
European Pharmaceutical Review
JANUARY 16, 2023
He warned, “Implementation of a CCS will require more than writing documents.”. Prior to November 2013 he worked for Merck Research Laboratories in Summit, New Jersey as the Senior Principal Scientist in early phase drug development. Dr Tony Cundell has a PhD in Microbiology from the Lincoln University, New Zealand.
Express Pharma
DECEMBER 31, 2024
Panelists in this video: + Mr G Raghuraman, AGM-Quality, Bafna Pharmaceuticals (Moderator) + Mr Mathivanan Rajagopal, VP and Head R&D, Axxlent Pharma Science + Dr Mohan Lakshminarayan, Director – Operation & System, Fourrts (India) Laboratories + Mr Sachin Sundar. needs to invest more in R&D.
Expert insights. Personalized for you.
246 
Let's personalize your content